MedDataX Logo

Social Cognition in Ageing and in Frontotemporal Lobar Degeneration

NCT ID: NCT01962064

Last Updated: 2013-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the age and the neurodegenerative disease effects on social cognition. Secondary goals are to better understand the relationships between different component of social cognition, executive functioning, and behavior and describing the neuronal substrates associated to the alteration of the social cognition in ageing and dementia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frontotemporal Lobar Degeneration Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Semantic demantia

cognitive assessment and Brain imaging examination MRI of patient with the semantic variant of primary progressive aphasia

Group Type EXPERIMENTAL

Cognitive assessment

Intervention Type BEHAVIORAL

Brain imaging examination MRI

Intervention Type OTHER

Frontotemporal dementia

cognitive assessment and Brain imaging examination MRI of patients with the behavioral variant of frontotemporal lobar degeneration

Group Type EXPERIMENTAL

Cognitive assessment

Intervention Type BEHAVIORAL

Brain imaging examination MRI

Intervention Type OTHER

Elderly

cognitive assessment and Brain imaging examination MRI of healthy elderly subjects

Group Type EXPERIMENTAL

Cognitive assessment

Intervention Type BEHAVIORAL

Brain imaging examination MRI

Intervention Type OTHER

Young

cognitive assessment and Brain imaging examination MRI of young subjects

Group Type EXPERIMENTAL

Cognitive assessment

Intervention Type BEHAVIORAL

Brain imaging examination MRI

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive assessment

Intervention Type BEHAVIORAL

Brain imaging examination MRI

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All the participants

* Age between 40 and 80 years
* Minimum of 7 years of education
* French native speaker
* Healthy subjects

* Non pathological Dementia rating scale score
* Patients

* Clinical diagnosis of frontotemporal lobar degeneration

Exclusion Criteria

* Chronic neurological disease
* Encephalitis
* Endocrinal disease
* Hepatic disease
* Case history of head injury with loss of consciousness of more than one hour
* Case history of stroke
* Case history of cancer during the five last years except squamous cell carcinomas
* Alcoholism or drug addiction
* Major psychiatric disorders according the Diagnostic and Statistical Manual of Mental Disorders
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role collaborator

University Hospital, Caen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vincent de La Sayette, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Caen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Inserm - EPHE - University of Caen U1077

Caen, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Julien Chavant

Role: CONTACT

Phone: 231065495

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-A00681-40

Identifier Type: -

Identifier Source: org_study_id